Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Deep Medicine Acquisition (DMAQ) Competitors

DMAQ vs. TRUG, SRM, IMTE, AQB, BHAT, SPGC, BBIG, MICS, YMAT, and SONY

Should you be buying Deep Medicine Acquisition stock or one of its competitors? The main competitors of Deep Medicine Acquisition include TruGolf (TRUG), SRM Entertainment (SRM), Integrated Media Technology (IMTE), AquaBounty Technologies (AQB), Fujian Blue Hat Interactive Entertainment Technology (BHAT), Sacks Parente Golf (SPGC), Vinco Ventures (BBIG), Singing Machine (MICS), J-Star (YMAT), and Sony Group (SONY). These companies are all part of the "recreation" industry.

Deep Medicine Acquisition vs.

Deep Medicine Acquisition (NASDAQ:DMAQ) and TruGolf (NASDAQ:TRUG) are both small-cap unclassified companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends, community ranking and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Deep Medicine AcquisitionN/A N/A N/A
TruGolf N/A N/A -21.06%

In the previous week, TruGolf had 8 more articles in the media than Deep Medicine Acquisition. MarketBeat recorded 8 mentions for TruGolf and 0 mentions for Deep Medicine Acquisition. TruGolf's average media sentiment score of 0.71 beat Deep Medicine Acquisition's score of 0.00 indicating that TruGolf is being referred to more favorably in the news media.

Company Overall Sentiment
Deep Medicine Acquisition Neutral
TruGolf Positive

Deep Medicine Acquisition has higher earnings, but lower revenue than TruGolf.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Deep Medicine AcquisitionN/AN/AN/AN/AN/A
TruGolf$20.35M0.29-$360K-$0.42-1.16

TruGolf received 1 more outperform votes than Deep Medicine Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Deep Medicine AcquisitionN/AN/A
TruGolfOutperform Votes
1
50.00%
Underperform Votes
1
50.00%

TruGolf has a consensus target price of $2.00, indicating a potential upside of 309.84%. Given TruGolf's stronger consensus rating and higher probable upside, analysts clearly believe TruGolf is more favorable than Deep Medicine Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Deep Medicine Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
TruGolf
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Deep Medicine Acquisition has a beta of 0.02, meaning that its share price is 98% less volatile than the S&P 500. Comparatively, TruGolf has a beta of -0.85, meaning that its share price is 185% less volatile than the S&P 500.

18.4% of Deep Medicine Acquisition shares are owned by institutional investors. Comparatively, 3.2% of TruGolf shares are owned by institutional investors. 1.7% of Deep Medicine Acquisition shares are owned by company insiders. Comparatively, 37.2% of TruGolf shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

TruGolf beats Deep Medicine Acquisition on 8 of the 11 factors compared between the two stocks.

Get Deep Medicine Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DMAQ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DMAQ vs. The Competition

MetricDeep Medicine AcquisitionHolding Offices IndustryUnclassified SectorNASDAQ Exchange
Market Cap$2.28M$469.41M$124.73M$9.12B
Dividend YieldN/A7.20%5.15%3.98%
P/E RatioN/A2.501.1717.51
Price / SalesN/A141.551.0383.27
Price / CashN/A66.5389.1837.67
Price / BookN/A4.891.014.72
Net IncomeN/A$34.48M$1.73M$224.62M

Deep Medicine Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DMAQ
Deep Medicine Acquisition
N/A$0.49
-6.5%
N/A-93.8%$2.13MN/A0.0093High Trading Volume
TRUG
TruGolf
2.9649 of 5 stars
$0.53
-7.7%
$2.00
+281.0%
N/A$6.24MN/A-1.2593Analyst Upgrade
Short Interest ↓
Analyst Revision
News Coverage
SRM
SRM Entertainment
0.987 of 5 stars
$0.46
+1.1%
N/A-77.7%$4.74M$5.76M-1.11N/AShort Interest ↓
News Coverage
Gap Down
IMTE
Integrated Media Technology
N/A$1.32
+2.5%
N/A-48.8%$4.52M$370,000.000.0010Short Interest ↓
Negative News
Gap Down
AQB
AquaBounty Technologies
0.9635 of 5 stars
$0.89
+12.5%
N/A-73.4%$3.07M$1.26M-0.05100Short Interest ↓
Gap Down
BHAT
Fujian Blue Hat Interactive Entertainment Technology
0.8127 of 5 stars
$0.06
-8.6%
N/A-96.1%$854,000.00$73.69M0.0080Short Interest ↑
Gap Up
SPGC
Sacks Parente Golf
2.3497 of 5 stars
$0.29
+1.6%
N/A-86.1%$531,000.00$350,000.00-0.0818Short Interest ↓
BBIG
Vinco Ventures
N/A$0.03
+2,900.0%
N/A+0.0%$374,000.00N/A0.0050
MICS
Singing Machine
N/A$0.04
-1.7%
N/A-96.2%$176,000.00$29.05M0.0027Gap Up
High Trading Volume
YMAT
J-Star
N/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading Volume
SONY
Sony Group
2.4267 of 5 stars
$20.92
+1.3%
$24.00
+14.8%
+472.8%$126.49B$90.19B17.12113,000News Coverage

Related Companies and Tools


This page (NASDAQ:DMAQ) was last updated on 1/31/2025 by MarketBeat.com Staff
From Our Partners